Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal Treatment in Adolescents With Gender Dysphoria
NCT06351501Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2024
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch, Estrogen vaginal cream in gender dysphoria (GD), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2024; status: recruiting.
02
Drugs
Testosterone TEPI patchEstrogen vaginal cream
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT06351501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06351501.